{"id":52796,"date":"2023-09-20T09:38:29","date_gmt":"2023-09-20T09:38:29","guid":{"rendered":"https:\/\/medsname.com\/tibofem\/"},"modified":"2026-04-30T10:18:08","modified_gmt":"2026-04-30T10:18:08","slug":"tibofem","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/tibofem\/","title":{"rendered":"Tibofem"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>\ud83d\udca1 R\u0103spuns rapid<\/strong><\/p>\n<p style=\"margin:0;\"><strong>Tibofem<\/strong> este <strong>tibolon 2,5 mg<\/strong>, un steroid sintetic care produce activitate estrogenic\u0103, progestogenic\u0103 \u0219i androgen\u0103 u\u0219oar\u0103 dup\u0103 metabolizare specific\u0103 \u021besuturilor. Utilizat pentru ameliorarea simptomelor menopauzei \u0219i prevenirea osteoporozei la femeile cu cel pu\u021bin 1 an de la menopauz\u0103. Spre deosebire de terapia hormonal\u0103 substitutiv\u0103 standard, tibolonul nu necesit\u0103 un progestin separat. Are un profil de risc distinct \u2014 <strong>risc u\u0219or crescut de accident vascular cerebral la femeile peste 60 de ani<\/strong>, \u0219i un risc u\u0219or crescut de recidiv\u0103 la femeile cu antecedente de cancer de s\u00e2n.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#f4f8fb;border-left:4px solid #2c7cb0;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.95em;\">\n<strong>\ud83d\udd12 Ce beneficia\u021bi cu MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret simplu (f\u0103r\u0103 denumirea medicamentului pe exterior) \u00b7 Livrare worldwide \u00b7 Citeste-ne <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">Peste 1.400 de recenzii ale clien\u021bilor<\/a>\n<\/div>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare comand\u0103 MedsBase este expediat\u0103 de la un produc\u0103tor certificat WHO-GMP \u00een ambalaj simplu, complet discret \u2014 nimic pe exterior nu identific\u0103 con\u021binutul sau farmacia. Pl\u0103\u021bile cu cardul sunt procesate printr-un on-ramp crypto reglementat; descriptorul din extrasul de cont este numele procesatorului (un procesator de pl\u0103\u021bi cu card reglementat) \u2014 niciodat\u0103 \u201cMedsBase\u201d sau orice legat de farmacie. Pl\u0103\u021bile crypto prin Plisio r\u0103m\u00e2n complet anonime. Fiecare colet este acoperit de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>.<\/p>\n<h2><strong>Ce este Tibofem?<\/strong><\/h2>\n<p>Tibofem este un medicament generic marca al <strong>tibolon 2,5 mg<\/strong>, un regulator selectiv al activit\u0103\u021bii estrogenice \u00een \u021besuturi (STEAR). Tibolonul este un steroid sintetic care este metabolizat \u00een diferite \u021besuturi \u00een compu\u0219i cu efecte asem\u0103n\u0103toare estrogenilor, progestinelor sau androgenilor \u2014 produc\u00e2nd un profil favorabil \u00een unele \u021besuturi \u0219i mai pu\u021bin\u0103 activitate \u00een altele. Fabricat de Cipla.<\/p>\n<p>Profil clinic: <strong>estrogenic \u00een os, creier \u0219i vagin<\/strong> (alinierea simptomelor), <strong>progestogenic \u00een endometru<\/strong> (nu stimuleaz\u0103 proliferarea endometrial\u0103 \u2014 nu este necesar un progestin separat), <strong>androgenic \u00een s\u00e2n \u0219i ficat<\/strong> (poate ajuta la libido; poate afecta \u0219i profilul lipidic).<\/p>\n<h2><strong>Utiliz\u0103ri clinice<\/strong><\/h2>\n<ul>\n<li><strong>Simptome vasomotorii menopauzale<\/strong> (furnic\u0103turi, transpira\u021bii nocturne) \u2014 reducere de ~70\u201380% \u00een studii.<\/li>\n<li><strong>Sindromul genitourinar al menopauzei<\/strong> \u2014 uscare vaginal\u0103, dispareunie.<\/li>\n<li><strong>Prevenirea osteoporozei postmenopauzale<\/strong> \u2014 reduce riscul de fractur\u0103 vertebral\u0103.<\/li>\n<li><strong>Femeile care prefer\u0103 terapie hormonal\u0103 cu un singur agent<\/strong> \u2014 nu este necesar\u0103 o tablet\u0103 separat\u0103 de progestin.<\/li>\n<li><strong>Unele femei raporteaz\u0103 beneficii privind libidoul<\/strong> datorit\u0103 activit\u0103\u021bii androgenice u\u0219oare a tibolonului (unic\u0103 \u00eentre op\u021biunile de terapie hormonal\u0103).<\/li>\n<\/ul>\n<h2><strong>Criterii de \u00eencepere<\/strong><\/h2>\n<ul>\n<li>Cel pu\u021bin <strong>12 luni de la ultima menstrua\u021bie<\/strong> (tibolonul la femeile perimenopauzale poate cauza s\u00e2nger\u0103ri neregulate).<\/li>\n<li>Menopauz\u0103 natural\u0103 sau chirurgical\u0103 (post-histerectomie, post-ooforectomie bilateral\u0103).<\/li>\n<li>Simptome suficient de semnificative pentru a justifica tratamentul.<\/li>\n<li>F\u0103r\u0103 contraindica\u021bii (vezi mai jos).<\/li>\n<\/ul>\n<h2><strong>Cum se administreaz\u0103<\/strong><\/h2>\n<ol>\n<li>Lua\u021bi <strong>o tablet\u0103 (2,5 mg) o dat\u0103 pe zi<\/strong>, aproximativ la aceea\u0219i or\u0103 \u00een fiecare zi, cu ap\u0103. Cu sau f\u0103r\u0103 m\u00e2ncare.<\/li>\n<li>Efectul asupra simptomelor vasomotor \u00eencepe de obicei \u00een 4\u20138 s\u0103pt\u0103m\u00e2ni; r\u0103spunsul maxim la 3 luni.<\/li>\n<li>Doze zilnice continue, \u00een fiecare zi \u2014 f\u0103r\u0103 pauze ciclice.<\/li>\n<li>Dac\u0103 \u00eencepe\u021bi \u00een decurs de 12 luni de la ultima menstrua\u021bie, s\u00e2nger\u0103rile neregulate sunt mai probabile; a\u0219tepta\u021bi cel pu\u021bin 1 an dup\u0103 menopauz\u0103.<\/li>\n<li>Reevalua\u021bi anual necesitatea continu\u0103rii. Majoritatea ghidurilor recomand\u0103 cea mai mic\u0103 doz\u0103 eficient\u0103 pentru cea mai scurt\u0103 perioad\u0103 eficient\u0103.<\/li>\n<\/ol>\n<h2><strong>Siguran\u021b\u0103 \u2014 Studiile LIFT \u0219i LIBERATE<\/strong><\/h2>\n<p>Dou\u0103 studii importante au conturat \u00een\u021belegerea siguran\u021bei tibolonului:<\/p>\n<ul>\n<li><strong>Studiul LIFT (preven\u021bia osteoporozei la femeile \u00een v\u00e2rst\u0103):<\/strong> a ar\u0103tat <strong>risc crescut de accident vascular cerebral<\/strong> la femeile peste 60 de ani care luau tibolon. Acum nu se recomand\u0103 utilizarea la femeile peste 60 de ani pentru ini\u021bierea tratamentului.<\/li>\n<li><strong>Studiul LIBERATE (supravie\u021buitoarelor de cancer de s\u00e2n):<\/strong> a ar\u0103tat <strong>recidiv\u0103 crescut\u0103 a cancerului de s\u00e2n<\/strong> c\u00e2nd tibolonul a fost utilizat la femei cu antecedente de cancer de s\u00e2n. Contraindicat la supravie\u021buitoarele de cancer de s\u00e2n.<\/li>\n<li>La femeile sub 60 de ani f\u0103r\u0103 antecedente de cancer de s\u00e2n, tibolonul are un profil de siguran\u021b\u0103 rezonabil, cu eficacitate comparabil\u0103 cu terapia hormonal\u0103 combinat\u0103 \u00een doze mici.<\/li>\n<\/ul>\n<h2><strong>Efecte Secundare<\/strong><\/h2>\n<p><strong>Frecvente:<\/strong> secre\u021bii vaginale, sensibilitate mamar\u0103 (mai pu\u021bin dec\u00e2t terapia hormonal\u0103 combinat\u0103), cre\u0219tere \u00een greutate (u\u0219oar\u0103), dureri abdominale inferioare, m\u0103rire a s\u00e2nilor.<\/p>\n<p><strong>Mai pu\u021bin frecvente:<\/strong> efecte androgenice \u2014 acnee u\u0219oar\u0103, p\u0103r facial crescut, piele gras\u0103 (datorit\u0103 activit\u0103\u021bii androgenice slabe a tibolonului), modific\u0103ri ale st\u0103rii de spirit.<\/p>\n<p><strong>Grave (rare):<\/strong> accident vascular cerebral (\u00een special la femeile peste 60 de ani), recidiv\u0103 a cancerului de s\u00e2n (la supravie\u021buitoarele de cancer de s\u00e2n), tromboembolism venos (mai mic dec\u00e2t la terapia hormonal\u0103 combinat\u0103 oral\u0103, dar nu zero), s\u00e2nger\u0103ri uterine nea\u0219teptate (investiga\u021bi).<\/p>\n<h2><strong>Cine nu ar trebui s\u0103 ia Tibofem<\/strong><\/h2>\n<ul>\n<li><strong>Femeile peste 60 de ani care \u00eencep noua terapie hormonal\u0103<\/strong> (risc de accident vascular cerebral) \u2014 utiliza\u021bi alternative<\/li>\n<li><strong>Istoric de cancer de s\u00e2n<\/strong> \u2014 contraindicat conform LIBERATE<\/li>\n<li>Istoric de cancer dependent de estrogen sau s\u00e2nger\u0103ri vaginale neexplicate<\/li>\n<li>Tromboembolism venos, tromboz\u0103 venoas\u0103 profund\u0103 sau embolie pulmonar\u0103 actual\u0103 sau \u00een istoric<\/li>\n<li>Istoric de accident vascular cerebral sau atac ischemic tranzitoriu<\/li>\n<li>Boal\u0103 hepatic\u0103 activ\u0103<\/li>\n<li>Sarcin\u0103 cunoscut\u0103 (nu ar trebui s\u0103 apar\u0103 post-menopauz\u0103)<\/li>\n<li>\u00cen ultimele 12 luni de la ultima menstrua\u021bie (s\u00e2nger\u0103ri neregulate)<\/li>\n<li>Hipersensibilitate cunoscut\u0103<\/li>\n<\/ul>\n<h2><strong>Tibolon vs THS combinat \u2014 Schema decizional\u0103<\/strong><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:12px 0;\">\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Considera\u021bii<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Tibolon<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">THS combinat (estrogen+progestin)<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Comprimate pe zi<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">1<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">1 sau 2 (\u00een func\u021bie de regim)<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Profilul s\u00e2nger\u0103rilor<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">~90% f\u0103r\u0103 s\u00e2nger\u0103ri dup\u0103 3 luni<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">S\u00e2ngerare de retragere (secven\u021bial\u0103) sau absen\u021b\u0103 de s\u00e2nger\u0103ri (continuu-combinat)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Libidou<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Beneficiu androgen u\u0219or raportat<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Neutru sau u\u0219or inhibator<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Utilizare la femei peste 60 de ani<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Evita\u021bi ini\u021bierea<\/strong> (risc de accident vascular cerebral)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Raport risc-beneficiu nefavorabil peste 60 de ani<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Supravie\u021buitoare de cancer de s\u00e2n<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>Contraindica\u021bii<\/strong> (LIBERATE)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Contraindica\u021bii<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Risc de TEV<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Sc\u0103zut (mai mic dec\u00e2t terapia hormonal\u0103 combinat\u0103 oral\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Moderat (administrare oral\u0103, mai ridicat)<\/td>\n<\/tr>\n<\/table>\n<h2><strong>Depozitare<\/strong><\/h2>\n<p>Se p\u0103streaz\u0103 la temperatura camerei (15\u201325 \u00b0C \/ 59\u201377 \u00b0F), departe de umiditate. P\u0103stra\u021bi \u00een ambalajul original.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Tibolonul este THS?<\/h3>\n<p>Da, \u00een esen\u021b\u0103 \u2014 este o form\u0103 de terapie hormonal\u0103 pentru simptomele menopauzei. Difera de THS clasic deoarece o singur\u0103 tablet\u0103 ofer\u0103 efecte asem\u0103n\u0103toare estrogenului, progestinului \u0219i u\u0219or androgenice, astfel \u00eenc\u00e2t nu este nevoie de un progestin separat.<\/p>\n<h3 class=\"wp-block-heading\">Pot \u00eencepe tibolon dac\u0103 \u00eenc\u0103 am menstrua\u021bii?<\/h3>\n<p>Nu. Tibolonul provoac\u0103 s\u00e2nger\u0103ri neregulate la femeile perimenopauzale. A\u0219tepta\u021bi p\u00e2n\u0103 la 12 luni de la ultima menstrua\u021bie.<\/p>\n<h3 class=\"wp-block-heading\">Voi s\u00e2ngera pe tibolon?<\/h3>\n<p>Aproximativ 90% dintre femei nu mai au s\u00e2nger\u0103ri dup\u0103 3 luni de administrare a tibolonului. S\u00e2nger\u0103rile nea\u0219teptate \u00een primele 3 luni sunt frecvente \u0219i de obicei se atenueaz\u0103. S\u00e2nger\u0103rile persistente dup\u0103 6 luni necesit\u0103 investiga\u021bii.<\/p>\n<h3 class=\"wp-block-heading\">Tibolonul este mai sigur dec\u00e2t THS combinat?<\/h3>\n<p>Mixt. Tibolonul prezint\u0103 un risc mai mic de tromboz\u0103 venoas\u0103 (VTE) dec\u00e2t terapia hormonal\u0103 substitutiv\u0103 (THS) combinat\u0103 oral\u0103, dar un risc u\u0219or crescut de accident vascular cerebral la femeile peste 60 de ani (studiu LIFT) \u0219i este contraindicat la supravie\u021buitoarele de cancer de s\u00e2n (LIBERATE). La femeile sub 60 de ani f\u0103r\u0103 antecedente de cancer de s\u00e2n, reprezint\u0103 o op\u021biune rezonabil\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 trec de la THS combinat\u0103 la tibolon?<\/h3>\n<p>Da, dar de obicei dup\u0103 12 luni de THS stabil\u0103. Discuta\u021bi cu un medic - trecerea poate implica o suprapunere scurt\u0103 sau o perioad\u0103 de \u00eentrerupere, \u00een func\u021bie de regimul actual.<\/p>\n<h3 class=\"wp-block-heading\">Tibolonul ajut\u0103 la libido?<\/h3>\n<p>Unele femei raporteaz\u0103 beneficii pentru libido datorate activit\u0103\u021bii androgenice u\u0219oare a tibolonului. Aceasta este o caracteristic\u0103 unic\u0103 \u00een compara\u021bie cu THS standard bazat\u0103 pe estrogen.<\/p>\n<h3 class=\"wp-block-heading\">Tibolonul provoac\u0103 cre\u0219tere \u00een greutate?<\/h3>\n<p>Sunt raportate modific\u0103ri mici de greutate (~1\u20132 kg). Tibolonul este \u00een general neutru din punct de vedere al greut\u0103\u021bii \u00een studiile controlate, de\u0219i exist\u0103 varia\u021bii individuale.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2t timp pot lua tibolon?<\/h3>\n<p>Ghidul modern: cea mai mic\u0103 doz\u0103 eficient\u0103 pentru cea mai scurt\u0103 durat\u0103 eficient\u0103. Evaluare anual\u0103. Datele privind siguran\u021ba pe termen lung sunt lini\u0219titoare pentru femeile sub 60 de ani f\u0103r\u0103 contraindica\u021bii.<\/p>\n<h3 class=\"wp-block-heading\">Produse conexe pentru s\u0103n\u0103tatea hormonal\u0103 \u0219i a femeii<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/premarin\/\">Premarin (Estrogeni conjuga\u021bi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/premarin-cream\/\">Premarin Crem\u0103 (Estrogen vaginal)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/progynova\/\">Progynova (Valerat de estradiol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/endogest\/\">Endogest (Progesteron\u0103 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gestoford\/\">Gestoford (Progesteron\u0103 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gestheal\/\">Gestheal (Progesteron\u0103 200 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/susten-capsule\/\">Capsule Susten (Progesteron\u0103)<\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.9em;\">\n<p style=\"margin:0;\"><strong>\u2695\ufe0f Disclaimer medical:<\/strong> Informa\u021biile au caracter educa\u021bional \u0219i nu \u00eenlocuiesc sfatul medical. Terapiile hormonale prezint\u0103 riscuri specifice (cancer de s\u00e2n, tromboz\u0103 venoas\u0103, accident vascular cerebral, cancer endometrial \u00een cazul estrogenului neopozat) \u2014 consulta\u021bi un medic \u00eenainte de a \u00eencepe, \u00eentrerupe sau modifica orice tratament hormonal. Raportul risc-beneficiu depinde de istoricul medical personal \u0219i familial.<\/p>\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Women's Health<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/livial\/\">Livial<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/v-gel\/\">V-Gel<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/premarin\/\">Premarin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/premarin-cream\/\">Premarin Cream<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/endogest\/\">Endogest<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<h5>\u2705 Reduce simptomele menopauzei<br \/>\n\u2705 Men\u021bine densitatea osoas\u0103<br \/>\n\u2705 Reduce riscul de osteoporoz\u0103<\/h5>\n<p><span style=\"color: #999999;\">Tibofem con\u021bine Tibolon<\/span><\/p>","protected":false},"featured_media":52797,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3519,3502],"product_tag":[3520],"class_list":{"0":"post-52796","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-hormone-replacement-therapy-hrt-medication-for-menopause","8":"product_cat-womens-health","9":"product_tag-tibolone","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-variable","16":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/52796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=52796"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/52797"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=52796"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=52796"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=52796"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=52796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}